MedPath

Combined Exercise and Nutritional Intervention in GI Cancer Patients

Not Applicable
Recruiting
Conditions
Pancreatic Cancer
Diet
Exercise
Gastric Cancer
Interventions
Behavioral: Combined Exercise and Dietary Intervention (CEDI)
Behavioral: Standard Care
Registration Number
NCT05420259
Lead Sponsor
Hospital Beatriz Ângelo
Brief Summary

Although some studies have focused on the role of exercise on inflammation and cytokine expression in cancer patients undergoing treatment and survivors, to our knowledge none have investigated the effect of exercise during neoadjuvant treatment as a complementary therapy to 1) modulate inflammation which may have a positive influence on chemotherapy response and 2) preserve or improve skeletal muscle, thus preventing cancer cachexia. Furthermore, we believe that the neoadjuvant treatment period could be a window of opportunity to optimize patient's nutritional status before surgery, which until now has been under used.

Bearing in mind that nutritional interventions may also influence IL-6, our hypothesis is that a Combined Exercise and Dietary Intervention (CEDI) may induce positive alterations in cytokine profile and increase NK cell infiltration of the tumor in gastric and pancreatic cancer patients submitted to neo-adjuvant therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
68
Inclusion Criteria
  • gastric or pancreatic cancer stage II/III, eligible for neoadjuvant chemotherapy,
  • age higher than 40 years and lower than 80 years,
  • ECOG (Eastern Cooperative Oncology Group) functional status: 0-2,
  • sedentary/low physical activity level.
Read More
Exclusion Criteria
  • life expectancy less than 12 months at inclusion,
  • chemotherapy regimen other than 5-Fluorouracil, Folinic acid, Oxaliplatin, Docetaxel (FLOT) for gastric and 5-Fluorouracil, Irinotecan and Oxaliplatin (FOLFIRINOX) or gemcitabine for pancreatic cancer,
  • metastatic disease,
  • chronic anti-inflammatory medication use,
  • known inflammatory condition (rheumatoid arthritis, ankylosing spondylitis or chronic active hepatitis)
  • cardiovascular, respiratory or musculoskeletal or joint problems that preclude moderate physical activity.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Combined Exercise and Dietary InterventionCombined Exercise and Dietary Intervention (CEDI)Intervention aimed at conveying a supervised combined moderate aerobic and resistance training, once a week with a duration of 40-60 minutes plus daily home exercise, personalized according to patients' age and functional status. Dietary intervention aimed at a one-on-one nutritional counseling. In the first visit a dietary plan is designed and one daily oral nutritional supplement (Fortimel Compact®, Nutricia) is given to meet the European Society of Parenteral and Enteral Nutrition (ESPEN) recommended intake.
ControlStandard CareStandard Care
Primary Outcome Measures
NameTimeMethod
Mean Change in interleukin 6 (IL6)8 weeks

IL6 circulating levels will be determined before and after combined exercise and dietary intervention (CEDI)

Secondary Outcome Measures
NameTimeMethod
Change in Immune cell infiltration profile on tumor specimen8 weeks

Peri-tumoral cell distribution (NK cells, T cells) will be determined before and after combined exercise and dietary intervention (CEDI)

Change in skeletal muscle8 weeks

Skeletal muscle using CT scan body composition analysis will be assessed before and after combined exercise and dietary intervention (CEDI)

Trial Locations

Locations (2)

Hospital Beatriz Ângelo

🇵🇹

Loures, Lisboa, Portugal

Hospital da Luz

🇵🇹

Lisboa, Portugal

© Copyright 2025. All Rights Reserved by MedPath